Sensei Biotherapeutics
(NASDAQ) SNSE
Sensei Biotherapeutics Financials at a Glance
Market Cap
$42.41M
Revenue (TTM)
$4.85M
Net Income (TTM)
$21.09M
EPS (TTM)
$-19.16
P/E Ratio
-1.65
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$31.56
Volume
262
Open
$30.80
Price
$31.56
Volume
262
Open
$30.80
Previous Close
$31.64
Daily Range
$30.10 - $31.56
52-Week Range
$5.25 - $36.76
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$31.56
Volume
262
Open
$30.80
Previous Close
$31.64
Daily Range
$30.10 - $31.56
52-Week Range
$5.25 - $36.76
SNSE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sensei Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
John K. Celebi, MBA
Website
senseibio.comHeadquarters
Rockville, MD 02210, US
SNSE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
5%
Net Income Margin
4%
Return on Equity
-70%
Return on Capital
-1%
Return on Assets
-92%
Earnings Yield
-60.61%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$42.41M
Shares Outstanding
1.34M
Volume
262
Short Interest
0.00%
Avg. Volume
300.82K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$22.29M
EBITDA
$20.91M
Operating Cash Flow
$20.45M
Capital Expenditure
$16.00K
Free Cash Flow
$20.47M
Cash & ST Invst.
$21.18M
Total Debt
$1.51M
Sensei Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$67.00K
+148.2%
Gross Margin
0.00%
N/A
Market Cap
$42.41M
N/A
Market Cap/Employee
$3.03M
N/A
Employees
14
N/A
Net Income
$4.72M
+39.3%
EBITDA
$4.68M
+38.5%
Quarterly Fundamentals
Net Cash
$19.68M
-47.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$59.00K
-96.1%
Short Term Debt
$1.45M
-37.4%
Return on Assets
-92.07%
N/A
Return on Invested Capital
-1.20%
N/A
Free Cash Flow
$3.86M
+33.3%
Operating Cash Flow
$3.86M
+33.3%